I picked a mistake in a broker research report that refers to 'statistical significance' in relation to AT1102 when in fact the research was conducted on AT1101. You'll find a chart at the bottom of Intersuisse document that has 'points 1-7' indicated on the chart. Point 7 refers to AT1102 and I was a bit concerned seeings though I picked up some ANP yesterday. I checked the corresponding asx releases and realised this is a mistake.
Not quite sure what the impact of Tysabri being available to MS sufferers again will have on ANP in the long term, however 6m shares traded yesterday and that justifies some attention. Intersuisse had a valuation of 18c I think....I'd better double check
